Pharmafile Logo
Pharmafocus logo
Advanced Search

CHMP begins rolling review of COVID oral antiviral

October 26, 2021
Manufacturing and Production

The EMA’s human medicine’s committee (CHMP) has initiated a rolling review of the investigational antiviral drug molnupiravir for the treatment …

News

Hospitals and pharmacies facing medicine shortages, says The London Economic

October 26, 2021
Manufacturing and Production

As the NHS faces soaring waiting lists and prepares for a winter surge in COVID cases, they must also gear …

News

MHRA licenses uterine fibroid treatment for women in Great Britain

October 26, 2021
Manufacturing and Production

The MHRA has granted a licence for Ryeqo (a relugolix combination therapy), for the treatment of moderate to severe symptoms …

News

Infectious disease expert says children between 5-11 could be vaccinated in November

October 25, 2021
Sales and Marketing

Infectious disease expert, Dr Anthony Fauci, has said that COVID-19 vaccines for children aged 5-11 could be available by early …

News

More people self-funding routine operations as NHS waiting lists hit record levels

October 25, 2021
Sales and Marketing

New data from the Private Healthcare Information Network (PHIN) reveals that people are increasingly opting to self-fund private treatment. This …

News

Novartis Phase III study into canakinumab does not meet primary endpoint

October 25, 2021
Sales and Marketing

Novartis have announced that their CANOPY-1 Phase III study, which evaluated the efficacy of canakinumab, did not meet its primary …

News

AstraZeneca biliary cancer drug shows improved survival rate in patients

October 25, 2021
Sales and Marketing

AstraZeneca has announced that its Imfinzi drug­­­, for the treatment of biliary tract cancer, has improved overall survival in patients …

News

Companion test for lung cancer approved by FDA

October 22, 2021
Medical Communications

The US FDA has approved of the Roche VENTANA PD-L1 Assay as a companion diagnostic for Tecentriq® in non-small cell …

News

Servier Phase III colorectal cancer trial fails to meet primary endpoint

October 22, 2021
Medical Communications

Global independent pharmaceutical group, Servier, has announced that the primary objective (progression free survival) of the Phase III SOLSTICE trial …

News

CDC approves the mixing of COVID shots

October 22, 2021
Medical Communications

The US Centers for Disease Control and Prevention (CDC) has backed a plan to allow COVID-19 vaccine boosters for recipients …

News

Xtrava Health Receives Emergency Use Authorisation for COVID-19 Ag Test

October 22, 2021
Medical Communications

The US FDA has issued an Emergency Use Authorisation (EUA) for Xtrava’s SPERA™ COVID-19 Ag Test. The easy-to-use, rapid lateral …

News

‘Plan C’ COVID response is urgent, doctors say

October 21, 2021
Business Services

UK Ministers are considering the implementation of a COVID ‘Plan C’. Cabinet Office officials are said to be discussing proposals …

News
mat-napo-pij34zrzeew-unsplash

Open Orphan to conduct first-ever COVID-19 human challenge trial

October 21, 2021
Business Services

Open Orphan has announced that they are progressing with their government-backed COVID-19 vaccine human challenge study. The company has signed …

News

Novartis extend COVID-19 vaccine deal with BioNTech

October 21, 2021
Business Services

Novartis announced today that it has signed an initial agreement with BioNTech SE to expand its support of the fill-and-finish …

News

Small Pharma’s Phase IIa DMT-assisted therapy begins

October 21, 2021
Business Services

Small Pharma has announced that the first patient has been dosed in the company’s Phase IIa clinical trial for its …

News

IXICO partner with Microsoft to enhance AI platform

October 20, 2021
Research and Development

IXICO, an AI data analytics company delivering insights into neuroscience, have announced a collaboration with Microsoft to develop its AI …

News

Synairgen COVID-19 treatment moves to Phase III trials

October 20, 2021
Research and Development

Synairgen PLC have said that its anti-viral treatment for severe lung infections is advancing to the final stage of clinical …

News

Pharma Innovation Award given to Stevanato Group for AI-ready vision Robot Unit

October 20, 2021
Research and Development

Stevanato Group, a global provider of processes and services for the Pharmaceutical and Healthcare industry, has been announced as a …

News
mufid-majnun-oi20ehignd4-unsplash

UK COVID deaths highest since March – Doctors call for urgent return of restrictions

October 20, 2021
Research and Development

Medical professionals in the NHS have urgently pleaded the UK government to reimpose COVID restrictions as UK COVID deaths reach …

News

England care staff shortage puts thousands at risk

October 20, 2021
Research and Development

Managers of community care services for over 15,000 people in England say that staff shortages have led to them turning …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026